Here’s Why Roche Looks Undervalued At $41
- Thursday, March 11, 2021, 7:15
- Market
- Add a comment
Roche’s ADR looks attractive at current levels of $41, as it is up only 17% from the levels it was at on March 23, 2020, when broader markets made a bottom due to the spread of Covid-19. This marks a significant underperformance compared to the S&P which has moved 73% since its March 2020 lows…
About the Author
admin123 has written 23527 stories on this site.
